DE69634512D1 - Traf-inhibitoren - Google Patents

Traf-inhibitoren

Info

Publication number
DE69634512D1
DE69634512D1 DE69634512T DE69634512T DE69634512D1 DE 69634512 D1 DE69634512 D1 DE 69634512D1 DE 69634512 T DE69634512 T DE 69634512T DE 69634512 T DE69634512 T DE 69634512T DE 69634512 D1 DE69634512 D1 DE 69634512D1
Authority
DE
Germany
Prior art keywords
traf
inhibitors
trafs
pharmaceuticals
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69634512T
Other languages
English (en)
Other versions
DE69634512T2 (de
Inventor
V Goeddel
Mike Rothe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen SF LLC
Genentech Inc
Original Assignee
Genentech Inc
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Tularik Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE69634512D1 publication Critical patent/DE69634512D1/de
Publication of DE69634512T2 publication Critical patent/DE69634512T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69634512T 1995-08-17 1996-08-14 Traf-inhibitoren Expired - Lifetime DE69634512T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US238295P 1995-08-17 1995-08-17
US2382P 1995-08-17
PCT/US1996/013129 WO1997007134A1 (en) 1995-08-17 1996-08-14 Traf inhibitors

Publications (2)

Publication Number Publication Date
DE69634512D1 true DE69634512D1 (de) 2005-04-28
DE69634512T2 DE69634512T2 (de) 2006-02-09

Family

ID=21700513

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69634512T Expired - Lifetime DE69634512T2 (de) 1995-08-17 1996-08-14 Traf-inhibitoren

Country Status (13)

Country Link
US (6) US5789550A (de)
EP (2) EP1568708A3 (de)
JP (2) JP4382878B2 (de)
AT (1) ATE291585T1 (de)
AU (1) AU709535B2 (de)
CA (1) CA2227174A1 (de)
DE (1) DE69634512T2 (de)
DK (1) DK0845005T3 (de)
ES (1) ES2239334T3 (de)
IL (1) IL122980A0 (de)
NZ (1) NZ315514A (de)
WO (1) WO1997007134A1 (de)
ZA (1) ZA966663B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA966663B (en) * 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.
AU713473B2 (en) 1996-12-23 1999-12-02 Immunex Corporation Receptor activator of NF-kappa B, receptor is member of TNF receptor superfamily
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6723517B1 (en) 1998-06-02 2004-04-20 Minerva Biotechnologies Corporation Use of self-assembled monolayers to probe the structure of a target molecule
WO1999067380A1 (en) * 1998-06-22 1999-12-29 Temple University - Of The Commonwealth System Of Higher Education c-Cbl SUPPRESSION OF NEOPLASTIC TRANSFORMATION
CA2385879A1 (en) * 1999-09-23 2001-03-29 Rigel Pharmaceuticals, Inc. Traf4 associated cell cycle proteins, compositions and methods of use
WO2002064786A1 (fr) * 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Nouveau gene tcif
CA2449487A1 (en) * 2001-06-07 2002-12-12 Pu Xia Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
CN1547486A (zh) 2001-06-26 2004-11-17 抗opgl抗体
US20030083304A1 (en) * 2001-10-09 2003-05-01 Smart Robert C. CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment
IL145918A0 (en) * 2001-10-14 2002-07-25 Ares Trading Sa Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells
WO2004012673A2 (en) * 2002-08-01 2004-02-12 Wyeth, Methods and reagents relating to inflammation and apoptosis
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
WO2008127975A2 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
WO2009143141A1 (en) * 2008-05-19 2009-11-26 Case Western Reserve University Method for treating cd40-mediated diseases
US10669345B2 (en) * 2008-05-19 2020-06-02 Case Western Reserve University Method for treating CD40-mediated diseases
EP2389452A2 (de) 2009-01-21 2011-11-30 Vertex Pharmaceuticals Incorporated Verfahren zur amplifikation von hepatitis-c-virus-nukleinsäuren
JP5721722B2 (ja) * 2009-10-01 2015-05-20 アルコン リサーチ， リミテッド オロパタジン組成物およびその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3613167A1 (de) * 1986-04-18 1987-10-29 Basf Ag Verwendung von tnf zur herstellung von arzneimitteln
US5108901A (en) 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP1132471A3 (de) * 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-bindende Proteine
US5318890A (en) 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
JPH10512443A (ja) * 1994-12-30 1998-12-02 ブリガム アンド ウイメンズ ホスピタル Ｔｒａｆ−媒介シグナルの制御
ZA966663B (en) * 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.

Also Published As

Publication number Publication date
EP0845005B1 (de) 2005-03-23
US20040087774A1 (en) 2004-05-06
US6294348B1 (en) 2001-09-25
EP1568708A3 (de) 2005-10-12
JP4382878B2 (ja) 2009-12-16
WO1997007134A1 (en) 1997-02-27
AU709535B2 (en) 1999-09-02
ZA966663B (en) 1998-02-06
DE69634512T2 (de) 2006-02-09
ES2239334T3 (es) 2005-09-16
JPH11511967A (ja) 1999-10-19
DK0845005T3 (da) 2005-08-01
US6063585A (en) 2000-05-16
IL122980A0 (en) 1998-08-16
NZ315514A (en) 1998-12-23
AU6723796A (en) 1997-03-12
EP0845005A1 (de) 1998-06-03
ATE291585T1 (de) 2005-04-15
EP1568708A2 (de) 2005-08-31
US5789550A (en) 1998-08-04
MX9800995A (es) 1998-10-31
US6004553A (en) 1999-12-21
JP2009065981A (ja) 2009-04-02
US6060303A (en) 2000-05-09
CA2227174A1 (en) 1997-02-27

Similar Documents

Publication Publication Date Title
ATE291585T1 (de) Traf-inhibitoren
NO961115L (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
ATE186551T1 (de) Medikamente bindendes protein
NO960767D0 (no) Protocadherinproteiner og deres anvendelse
CY1112101T1 (el) Νευροτροφικοι παραγοντες
NO985848D0 (no) Nytt protein og fremgangsmÕte for fremstilling av dette
DK0811063T3 (da) Kemokin-receptor 88C og dens antistoffer
DE69833014D1 (de) Menschliche toll homologen
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DE69535274D1 (de) Verwendung eines menschlichen interleukin-11 rezeptors
DE69933696D1 (de) Cytokinrezeptor-kette
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
DE69728897D1 (de) Saeugetierchemokine
ATE171217T1 (de) Methoden zur synthese und reinigung von peptiden
NO20005819D0 (no) Nye peptidfragmenter for rensing av proteiner
WO2001021794A3 (en) Smad associating polypeptides
RU94026276A (ru) Рецепторы интерлейкина-12 и антител

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: GENENTECH, INC., SOUTH SAN FRANCISCO, CALIF., US

Owner name: AMGEN SF, LLC, THOUSAND OAKS, CALIF., US

8364 No opposition during term of opposition